secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2026-01-09T23:59:59+00:00
Accession:  0001193125-26-008938
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics gets Nasdaq notice for missing annual meeting; meeting set for Jan 27, 2026
--------------------------------------------------------------------------------

- Received Nasdaq deficiency letter on Jan 8, 2026 for failing to hold annual meeting within 12 months of fiscal year end Dec 31, 2024.
- Company has 45 calendar days (until Feb 23, 2026) to regain compliance or submit a plan; Nasdaq may grant exception until June 29, 2026.
- Annual meeting already scheduled for Jan 27, 2026; upon holding it, compliance will be regained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526008938/0001193125-26-008938-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312526008938/d30095d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-008938

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer